SG11202009826PA - Method for large-scale production of lentivirus by using gmp-level serum-free suspension cells - Google Patents
Method for large-scale production of lentivirus by using gmp-level serum-free suspension cellsInfo
- Publication number
- SG11202009826PA SG11202009826PA SG11202009826PA SG11202009826PA SG11202009826PA SG 11202009826P A SG11202009826P A SG 11202009826PA SG 11202009826P A SG11202009826P A SG 11202009826PA SG 11202009826P A SG11202009826P A SG 11202009826PA SG 11202009826P A SG11202009826P A SG 11202009826PA
- Authority
- SG
- Singapore
- Prior art keywords
- lentivirus
- gmp
- scale production
- suspension cells
- free suspension
- Prior art date
Links
- 241000713666 Lentivirus Species 0.000 title 1
- 238000011031 large-scale manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000725 suspension Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
- C12M47/02—Separating microorganisms from the culture medium; Concentration of biomass
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
- C12M47/12—Purification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15041—Use of virus, viral particle or viral elements as a vector
- C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16041—Use of virus, viral particle or viral elements as a vector
- C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16051—Methods of production or purification of viral material
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810273392.7A CN110317791A (en) | 2018-03-29 | 2018-03-29 | The method of GMP grades of serum free suspension cell large-scale production slow virus |
| PCT/CN2019/080215 WO2019184996A1 (en) | 2018-03-29 | 2019-03-28 | Method for large-scale production of lentivirus by using gmp-level serum-free suspension cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202009826PA true SG11202009826PA (en) | 2020-11-27 |
Family
ID=68058573
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202009826PA SG11202009826PA (en) | 2018-03-29 | 2019-03-28 | Method for large-scale production of lentivirus by using gmp-level serum-free suspension cells |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US11845962B2 (en) |
| EP (1) | EP3778880A4 (en) |
| JP (1) | JP2021519108A (en) |
| KR (1) | KR20200136463A (en) |
| CN (1) | CN110317791A (en) |
| AU (1) | AU2019241301A1 (en) |
| SG (1) | SG11202009826PA (en) |
| WO (1) | WO2019184996A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110894494B (en) * | 2019-11-22 | 2022-09-27 | 广西梧州制药（集团）股份有限公司 | Method for large-scale high-density suspension culture of 293 cell high-yield adenovirus |
| CN113832112A (en) * | 2020-06-24 | 2021-12-24 | 重庆精准生物技术有限公司 | Mixing method and mixing system for preparing lentivirus |
| CN113265425A (en) * | 2021-05-08 | 2021-08-17 | 苏州博腾生物制药有限公司 | Suspension cell-based CAR-CD19 lentivirus preparation process |
| CN114990077A (en) * | 2022-08-01 | 2022-09-02 | 深圳市先康达生命科学有限公司 | Lentiviral packaging and purification method |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002348151A1 (en) | 2001-11-05 | 2003-05-19 | Genvec, Inc. | Viral vector production methods and compositions |
| US20030175688A1 (en) | 2002-03-15 | 2003-09-18 | Rukmini Pennathur-Das | Method for the purification and production of oncolytic adenoviruses |
| US20080026448A1 (en) | 2006-02-15 | 2008-01-31 | Lydersen Bjorn K | Production of HIV |
| AU2007240797B2 (en) | 2006-04-20 | 2013-05-23 | Wyeth Llc | Purification processes for isolating purified vesicular stomatitis virus from cell culture |
| CL2008003794A1 (en) | 2007-12-21 | 2009-03-20 | Wyeth Corp | Genetically modified vesicular stomatitis virus (vsv) comprising at least one amino acid mutation in a region of some of the m, g and l proteins of the virus; method to produce it; immunogenic composition comprising it; method of adapting a virus in a cell culture. |
| KR101504392B1 (en) | 2008-11-03 | 2015-03-19 | 크루셀 홀란드 비.브이. | Method for the production of adenoviral vectors |
| PL2782997T3 (en) * | 2011-11-24 | 2018-06-29 | Genethon | Scalable lentiviral vector production system compatible with industrial pharmaceutical applications |
| EP2682168A1 (en) | 2012-07-02 | 2014-01-08 | Millipore Corporation | Purification of biological molecules |
| CN103881984A (en) * | 2013-12-06 | 2014-06-25 | 深圳市赛百诺基因技术有限公司 | Methods for producing recombinant adenovirus and drug preparations of recombinant adenovirus with serum-free suspension cells |
| FR3014901B1 (en) | 2013-12-17 | 2017-06-09 | Genethon | PROCESS FOR PURIFYING ENHANCED VIRUSES OR VIRTORS |
| CN104371982A (en) | 2014-10-21 | 2015-02-25 | 武汉维诺赛生物技术有限公司 | Method for purifying slow virus |
| EP3054007A1 (en) | 2015-02-09 | 2016-08-10 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Recombinant adeno-associated virus particle purification comprising an immuno-affinity purification step |
| CN107043784A (en) * | 2016-02-05 | 2017-08-15 | 上海吉凯基因化学技术有限公司 | A kind of preparation method of slow virus carrier |
| CN107523555A (en) * | 2016-06-22 | 2017-12-29 | 武汉光谷人福生物医药有限公司 | The method for obtaining virus |
| CN107841482B (en) * | 2016-09-21 | 2021-07-27 | 上海倍谙基生物科技有限公司 | H9 subtype influenza vaccine produced by MDCK cell serum-free suspension culture technology |
| CN106434571A (en) * | 2016-10-19 | 2017-02-22 | 深圳源兴基因技术有限公司 | Method for preparing recombinant adenovirus by WAVE serum-free culture suspension cells |
| CN106474466B (en) | 2016-12-07 | 2018-04-13 | 申联生物医药（上海）股份有限公司 | A kind of preparation method of aftosa vaccine |
| CN107384877B (en) | 2017-08-18 | 2020-09-08 | 深圳源兴基因技术有限公司 | Method for purifying lentivirus |
| CN107630037A (en) | 2017-10-19 | 2018-01-26 | 和元生物技术（上海）股份有限公司 | A kind of purifying process for obtaining high-purity gland relevant viral vector |
| CN110317832B (en) | 2018-03-28 | 2022-07-05 | 西比曼生物科技（香港）有限公司 | GMP (good manufacturing practice) scale preparation method of purified preparation of recombinant lentiviral vector |
-
2018
- 2018-03-29 CN CN201810273392.7A patent/CN110317791A/en active Pending
-
2019
- 2019-03-28 US US17/041,578 patent/US11845962B2/en active Active
- 2019-03-28 KR KR1020207030733A patent/KR20200136463A/en unknown
- 2019-03-28 SG SG11202009826PA patent/SG11202009826PA/en unknown
- 2019-03-28 JP JP2021501071A patent/JP2021519108A/en active Pending
- 2019-03-28 AU AU2019241301A patent/AU2019241301A1/en active Pending
- 2019-03-28 EP EP19775992.1A patent/EP3778880A4/en active Pending
- 2019-03-28 WO PCT/CN2019/080215 patent/WO2019184996A1/en active Application Filing
-
2023
- 2023-10-31 US US18/498,879 patent/US20240060053A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20240060053A1 (en) | 2024-02-22 |
| KR20200136463A (en) | 2020-12-07 |
| EP3778880A4 (en) | 2021-12-29 |
| US20210363497A1 (en) | 2021-11-25 |
| CN110317791A (en) | 2019-10-11 |
| US11845962B2 (en) | 2023-12-19 |
| JP2021519108A (en) | 2021-08-10 |
| EP3778880A1 (en) | 2021-02-17 |
| WO2019184996A1 (en) | 2019-10-03 |
| AU2019241301A1 (en) | 2020-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202009826PA (en) | Method for large-scale production of lentivirus by using gmp-level serum-free suspension cells | |
| MX2016012419A (en) | Ibrutinib solid forms and production process therefor. | |
| EP3256439A4 (en) | Process for production of acrylic acid | |
| IL285816A (en) | Methods for clonal plant production | |
| IL271524A (en) | Cell culture process for making a glycoprotein | |
| WO2016012445A3 (en) | Process for the purification of poliovirus from cell cultures | |
| EP3830280A4 (en) | Method for production of novel diterpene scaffolds | |
| IL280556A (en) | Cell production method | |
| IL274746A (en) | Method for culture of cells | |
| HK1247849A1 (en) | Microcarriers, matrices and scaffolds for culturing mammalian cells and methods of manufacture | |
| GB2593104B (en) | System for optimization of hydrocarbon production | |
| GB201608060D0 (en) | Method of culturing T cells | |
| EP3587559A4 (en) | Production method for artificial pluripotent stem cells | |
| PL3755681T3 (en) | Method of 4-boronophenylalanine production | |
| EP3569693A4 (en) | Method for producing cell culture | |
| GB201911958D0 (en) | Methods of t cell production | |
| EP3133148A4 (en) | Method for mass culturing photosynthetic microalgae by additionally supplying environmental water | |
| SG11202108435WA (en) | Method for virus production | |
| SG11202011845XA (en) | Production method for culture supernatant preparation | |
| EP3196304A4 (en) | Method for improved high secretory production of proteins | |
| EP4053267A4 (en) | Method for producing t cell | |
| EP3851518A4 (en) | Method for producing intestinal cells from pluripotent stem cells | |
| EP3896155A4 (en) | Production method for genome-edited cells | |
| EP3863962C0 (en) | Process for the production of hydrogen | |
| HUP1800125A2 (en) | Process for production of iloprost |